Home Tags FDA

Tag: FDA

Ionis Pharmaceuticals (IONS) Stock: Here’s What You Need To Know

Ionis Pharmaceuticals (NASDAQ:IONS) After the market closed on December 23, Ionis had announced that it had received FDA approval, together with Biogen, for its Spinal...

Clovis Oncology (CLVS) Stock: The Low Down On Approval

Clovis Oncology (NASDAQ:CLVS) On Monday, Clovis Oncology stock closed higher by 9% after it announced that the FDA had approved its drug. The drug in...

Arrowhead Pharmaceuticals (ARWR) Stock: Here’s What You Need To Know

Arrowhead Pharmaceuticals (NASDAQ:ARWR) On Monday, Arrowhead Pharmaceuticals stock closed down by 1.58%, even though it announced that it had completely finished the deal with Amgen....

Dynavax Technologies (DVAX) Stock: Here’s What You Need To Know

Dynavax Technologies (NASDAQ:DVAX) On Monday, Dynavax Technologies stock closed the day lower by 64.55% after the company announced that the FDA has rejected Hepislav-B, its...

Inovio (INO) Stock: Here’s What You Need To Know

Inovio Pharmaceuticals (NASDAQ:INO) On Monday, Inovio Pharmaceuticals closed the day down by 17% after the company announced that the FDA had placed its trial initiation...

PTC Therapeutics (PTCT) Stock: Here’s What You Need To Know

PTC Therapeutics (NASDAQ:PTCT) On Monday, PTC Therapeutics fell by 40% to $7.97 per share after the company had announced that the FDA refused its appeal...

Durect Corp (DRRX) Stock: Here’s What You Need To Know

Durect Corp. (NASDAQ:DRRX) On Monday, Durect Corp stock fell by 32% after Pain Therapeutics (PTIE) received a Complete Response Letter -- CRL -- from the...

Sarepta Therapeutics (SRPT) Stock: Here’s What You Need To Know

Sarepta Therapeutics (NASDAQ:SRPT) On Monday, Sarepta's stock closed the day up 73.85% after the company announced that the FDA had given its drug Eteplirsen FDA...

Arena Pharmaceuticals (ARNA) Stock: Here’s What You Need To Know

Arena Pharmaceuticals (NASDAQ:ARNA) Arena Pharmaceuticals has been struggling to stay afloat as a company, especially with Belviq under performing in the obesity market. Thing are...

Aurinia Pharmaceuticals (AUPH) Stock: Here’s What You Need To Know

About a week ago Aurinia Pharmaceuticals cratered by 55.75% to close at $1.81 per share. The ironic thing is that the company had announced...

Sellas Life Sciences (SLS) Stock: Flying On FDA News

Sellas Life Sciences Group Inc (NASDAQ: SLS) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The...

Reviews

TradeMiner Review: Is It Worth Your While?

There are tons of trading tools out there, but none of them are quite like TradeMiner. The software doesn’t look at your...